Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by kynarron Oct 30, 2015 1:30pm
156 Views
Post# 24244160

RE:RE:RE:RE:RE:RE:So what next?

RE:RE:RE:RE:RE:RE:So what next?I'm very unsure what exactly the market was expecting. They reached over 50 millions within 7 months and everything points to it ramping up in October and beyond. The NR was super positive and they reiterated that they were on track for their 500 million goal. I also love the idea that the warrants would have expired as that means less dilution, and they still have the ability to do that later on at a higher SP, knowing they're not lacking in funds at the time. Did anyone expect more than the NR provided? Cuz they provided the best case scenario and the SP certainly isn't reflecting that right now. I'm confused. If I wasn't already heavily invested at a low SP, I'd be buying so many shares right now. GLTA.
Bullboard Posts